🔎 Trials Near Me

Beranda › Limfoma Sel B Besar Difus › California › Sacramento

Uji klinis Limfoma Sel B Besar Difus di Sacramento, CA

8 studi untuk Limfoma Sel B Besar Difus mencari peserta di lokasi sekitar Sacramento (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Menerima pesertaFase 2
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06500273

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Menerima pesertaFase 3
  • UC Davis Comprehensive Cancer Center, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06091865

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

Menerima pesertaFase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT05272384

Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Menerima pesertaFase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Jul 2026 · NCT05052528

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Menerima pesertaFase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jul 2026 · NCT06015880

Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy

Menerima pesertaFase 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT06854159

Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

Menerima pesertaFase 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jun 2026 · NCT06905509

Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma

Menerima pesertaFase 1/2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 10 Mar 2026 · NCT05256641

Uji klinis Limfoma Sel B Besar Difus di kota lain

Studi lain di Sacramento

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.